Moreover, our qRT‐PCR analysis, as well as microarray data, showed that mRNA expression levels of INHBA, IGF2, and TLR2, all of which are classified into the KRAS‐responsive gene sets, significantly increase in ameloblastoma compared to normal counterpart tissues. The gene discussed is IGF2; the disease is ameloblastoma.